Search Results 1081-1090 of 19328 for Hemoglobin

1. A Study of SC-006 in Subjects With Advanced Cancer - Mayo Clinic

   Hemoglobin ≥.0 g/dL;; Serum total bilirubin ≤.5× ULN or ≤× ULN for subjects with Gilbert's disease;; Serum ALT and AST ≤× ULN (≤× ULN if evidence of ...

2. Clinical trials - Oncology (Medical)

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

3. Estradiol-Receptor Blockade In Older Men And Women - Mayo Clinic

   ... (hemoglobin must meet Blood Bank requirements - Hgb ≥ 12.5 g/dL); drug or alcohol abuse, psychosis, depression, mania or severe anxiety;; acute or chronic ...

4. Testing the Addition of Ixazomib to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial - Mayo Clinic

   Hemoglobin ≥ 8 g/dL (obtained ≤ 14 days prior to randomization). Untransfused platelet count ≥ 75,000 cells/mm^3 (obtained ≤ 14 days prior to ...

5. Phase 1 Study of Intradermal LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1 - Mayo Clinic

   Marrow: Peripheral blood leukocyte count (WBC) < 3000/mm3, absolute neutrophils count ≤ 1500/mm3, platelets < 75000/mm3, or hemoglobin < 10 gm/dL. Hepatic ...

6. Low potassium (hypokalemia) Causes - Mayo Clinic

   The most common cause is potassium loss in urine due to prescription medicines that increase urination. These types of medicines, also known as water pills or ...

7. Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer - Mayo Clinic

   Hemoglobin >= 9 g/dL continuation of erythropoietin products is permitted; hemoglobin ... hemoglobin level; Calculated creatinine clearance must be >= 50 ml ...

8. Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments - Mayo Clinic

   Hemoglobin > 9 g/dL;; Creatinine concentration ≤ 1.4 mg/dL, or creatinine clearance > 40 mL/min;; Total bilirubin < 1.5 mg/dL, ALT+ AST levels ≤ 3 times ...

9. A Study of Pembrolizumab (MK-3475) Versus Placebo in Combination with Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer - Mayo Clinic

   Hemoglobin* ≥ 9 g/dL or ≥ 5.6 mmol/L. Renal. Creatinine ≤ 1.5 × ULN; OR; Measured or calculated** creatinine clearance (GFR can also be used instead of ...

10. Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma - Mayo Clinic

    Hemoglobin >= 8.0 g/dL (may receive red blood cell [RBC] transfusions); Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 mL/min ...